Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Trastuzumab (Herceptin), Paclitaxel, Carboplatin and Gemcitabine in Advanced Urothelial Cancer

This study has been completed.
Genentech, Inc.
Information provided by (Responsible Party):
University of Michigan Cancer Center Identifier:
First received: September 6, 2005
Last updated: January 20, 2015
Last verified: January 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2007
  Primary Completion Date: August 2004 (Final data collection date for primary outcome measure)